Urology Doctors in Evanston, IL Accepting Medicare

6 Urology doctors found. Showing 1 - 6

Peter M. Colegrove, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1000 Central St, Suite 720, Evanston, IL 60201 Phone: 847-475-8600    Fax: 847-475-8654

Mark Jonathan Schacht, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 800 Austin St, Suite 569e, Evanston, IL 60202 Phone: 847-328-5600    Fax: 847-328-9129

Thomas C. Keeler, MD Urology Medicare: Medicare Enrolled Practice Location: 1000 Central St, Suite 720, Evanston, IL 60201 Phone: 847-475-8600    Fax: 847-475-8654

Peter Thomas Vaselopulos, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 800 Austin St, Suite 569, Evanston, IL 60202 Phone: 847-328-5600    Fax: 847-328-9129

Charles B. Brendler, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 2650 Ridge Ave, Walgreen Building Suite 2507, Evanston, IL 60201 Phone: 847-570-2560    Fax: 847-570-2930

Leon Gershon Lome, MD Urology Medicare: Medicare Enrolled Practice Location: 800 Austin St, Suite 457e, Evanston, IL 60202 Phone: 847-328-8884    Fax: 847-328-9129

News Archive

Some colonoscopic technologies better at improving detection of adenomas

Recent advances in colonoscopic technology are featured in a number of studies presented at the Annual Scientific Meeting of the American College of Gastroenterology this week. In this research some technologies fare better than others at improving detection of potentially pre-cancerous growths in the colon known as adenomas.

Largest ever Canadian study on osteoporosis informs health policy

Dr David Goltzman and his team from the Research Institute of the McGill University Health Centre (RI MUHC) and McGill University - along with colleagues from across Canada - have issued new recommendations to public health authorities about how to best cope with osteoporosis, a bone disease which leads to increased risk of fracture, particularly in the elderly.

CHMP adopts positive opinion for ABRAXANE with gemcitabine for treatment of metastatic pancreas

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that the European Medicines Agency's: Committee for Medicinal Products for Human Use has adopted a positive opinion for ABRAXANE (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) in combination with gemcitabine for first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas.

Telestroke appears to be cost-effective for society

Researchers have found that using telemedicine to deliver stroke care, also known as telestroke, appears to be cost-effective for society. The research was recently published in the American Journal of Managed Care.

First Edition: June 25, 2010

Today's headlines reflect the latest news about the House passing a temporary ban on cuts in Medicare reimbursements to doctors, while Senate Democrats failed to gain approval for their jobs bill, which included enhanced Medicaid aid to states.

Read more Medical News

› Verified 2 days ago